Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 25,640 | 19,819 | 17,292 | 12,800 | 11,456 |
| Operating Income | -25,640 | -19,819 | -17,292 | -12,800 | -11,456 |
| Other Income | 728 | 735 | 743 | 1,072 | 118 |
| Pre-tax Income | -24,912 | -19,084 | -16,549 | -11,728 | -11,338 |
| Net Income Continuous | -24,912 | -19,084 | -16,549 | -11,728 | -11,338 |
| Net Income | $-24,912 | $-19,084 | $-16,549 | $-11,728 | $-11,338 |
| EPS Basic Total Ops | -0.62 | -0.48 | -0.43 | -0.34 | -9.34 |
| EPS Basic Continuous Ops | -0.62 | -0.48 | -0.43 | -0.34 | 0.08 |
| EPS Diluted Total Ops | -0.62 | -0.48 | -0.43 | -0.34 | -9.34 |
| EPS Diluted Continuous Ops | -0.62 | -0.48 | -0.43 | -0.34 | 0.08 |
| EBITDA(a) | $-25,572 | $-19,771 | $-17,278 | $-12,783 | $-11,439 |